CANCER:

Juvenile Myelomonocytic Leukemia

Related cancers:

‹

Leukemia (1622)

Acute Myelogenous Leukemia (726)

Acute Lymphocytic Leukemia (328)

Chronic Myeloid Leukemia (255)

Chronic Lymphocytic Leukemia (243)

B Acute Lymphoblastic Leukemia (126)

Childhood B Acute Lymphoblastic Leukemia (35)

T Acute Lymphoblastic Leukemia (35)

Hairy Cell Leukemia (16)

Chronic Myelomonocytic Leukemia (15)

Prolymphocytic Leukemia (12)

Acute Promyelocytic Leukemia (10)

Chronic Eosinophilic Leukemia (4)

Chronic Neutrophilic Leukemia (3)

Leukemia (1622)

Acute Myelogenous Leukemia (726)

Acute Lymphocytic Leukemia (328)

Chronic Myeloid Leukemia (255)

Chronic Lymphocytic Leukemia (243)

B Acute Lymphoblastic Leukemia (126)

Childhood B Acute Lymphoblastic Leukemia (35)

T Acute Lymphoblastic Leukemia (35)

Hairy Cell Leukemia (16)

Chronic Myelomonocytic Leukemia (15)

Prolymphocytic Leukemia (12)

Acute Promyelocytic Leukemia (10)

Chronic Eosinophilic Leukemia (4)

Chronic Neutrophilic Leukemia (3)

›

KRAS mutation KRAS mutation	Juvenile Myelomonocytic Leukemia Juvenile Myelomonocytic Leukemia	decitabine Sensitive: C4 – Case Studies
ETV6-FLT3 fusion ETV6-FLT3 fusion	Juvenile Myelomonocytic Leukemia Juvenile Myelomonocytic Leukemia	gilteritinib Sensitive: C4 – Case Studies
SETBP1 mutation + NRAS mutation SETBP1 mutation + NRAS mutation	Juvenile Myelomonocytic Leukemia Juvenile Myelomonocytic Leukemia	trametinib Sensitive: D – Preclinical